JPS5039272A - - Google Patents

Info

Publication number
JPS5039272A
JPS5039272A JP8929973A JP8929973A JPS5039272A JP S5039272 A JPS5039272 A JP S5039272A JP 8929973 A JP8929973 A JP 8929973A JP 8929973 A JP8929973 A JP 8929973A JP S5039272 A JPS5039272 A JP S5039272A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8929973A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP8929973A priority Critical patent/JPS5039272A/ja
Publication of JPS5039272A publication Critical patent/JPS5039272A/ja
Pending legal-status Critical Current

Links

JP8929973A 1973-08-10 1973-08-10 Pending JPS5039272A (hr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8929973A JPS5039272A (hr) 1973-08-10 1973-08-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8929973A JPS5039272A (hr) 1973-08-10 1973-08-10

Publications (1)

Publication Number Publication Date
JPS5039272A true JPS5039272A (hr) 1975-04-11

Family

ID=13966781

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8929973A Pending JPS5039272A (hr) 1973-08-10 1973-08-10

Country Status (1)

Country Link
JP (1) JPS5039272A (hr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10421744B2 (en) 2013-06-27 2019-09-24 Pfizer Inc. Heteroaromatic compounds and their use as dopamine D1 ligands

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10421744B2 (en) 2013-06-27 2019-09-24 Pfizer Inc. Heteroaromatic compounds and their use as dopamine D1 ligands
US11014909B2 (en) 2013-06-27 2021-05-25 Pfizer Inc. Heteroaromatic compounds and their use as dopamine D1 ligands

Similar Documents

Publication Publication Date Title
AR201758A1 (hr)
AU476761B2 (hr)
AU465372B2 (hr)
AR201235Q (hr)
AR201231Q (hr)
AU474593B2 (hr)
AU474511B2 (hr)
AU474838B2 (hr)
AU465453B2 (hr)
AU465434B2 (hr)
AU471343B2 (hr)
AU450229B2 (hr)
AU476714B2 (hr)
AR201229Q (hr)
AU466283B2 (hr)
AU476696B2 (hr)
AU472848B2 (hr)
AR199451A1 (hr)
AU477823B2 (hr)
AU461342B2 (hr)
AU471461B2 (hr)
AR200256A1 (hr)
AU476873B1 (hr)
AU477824B2 (hr)
AR201432A1 (hr)